sertraline has been researched along with Affective Disorders, Psychotic in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (30.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 5 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alexopoulos, GS; Banerjee, S; Flint, AJ; Marino, P; Meyers, BS; Mulsant, BH; Pollari, CD; Rothschild, AJ; Rudorfer, MV; Voineskos, AN; Whyte, EM; Wu, Y | 1 |
| Mizoguchi, Y; Monji, A | 1 |
| Andreescu, C; Blumberger, DM; Emeremni, C; Flint, AJ; Houck, P; Mazumdar, S; Meyers, BS; Mulsant, BH; Rothschild, AJ; Whyte, E | 1 |
| Flint, A; Ghosh, S; Meyers, B; Mulsant, B; Rothschild, A; Weissman, J; Whyte, E | 1 |
| Flint, AJ; Marino, P; Meyers, BS; Mulsant, BH; Rothschild, AJ; Rudorfer, MV; Whyte, EM | 1 |
| El Sheshai, A; Fayek, M; Kingsbury, SJ; Rady, A; Simpson, GM | 1 |
| Arolt, V; Baune, BT; Dannlowski, U; Deckert, J; Evers, S; Hetzel, G; Moeller, O; Nguyen, DH | 1 |
| Fawcett, JA; Gelenberg, A; Harrison, W; Hirschfeld, RM; Keller, MB; Klein, D; Kocsis, JH; McCullough, JP; Rush, AJ; Schatzberg, A | 1 |
| Baldessarini, RJ; Centorrino, F; Flood, JG; Frankenburg, FR; Kando, J; Volpicelli, SA | 1 |
| Atala, KD; Baer, L; Beer, DA; Eisen, JL; Phillips, KA; Rasmussen, SA | 1 |
7 trial(s) available for sertraline and Affective Disorders, Psychotic
| Article | Year |
|---|---|
Effect of Continuing Olanzapine vs Placebo on Relapse Among Patients With Psychotic Depression in Remission: The STOP-PD II Randomized Clinical Trial.
Topics: Adolescent; Adult; Affective Disorders, Psychotic; Aged; Antidepressive Agents; Antipsychotic Agents; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Olanzapine; Proportional Hazards Models; Secondary Prevention; Sertraline; Young Adult | 2019 |
Impact of prior pharmacotherapy on remission of psychotic depression in a randomized controlled trial.
Topics: Adult; Affective Disorders, Psychotic; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Female; Humans; Male; Olanzapine; Retreatment; Sertraline | 2011 |
Factors associated with non-completion in a double-blind randomized controlled trial of olanzapine plus sertraline versus olanzapine plus placebo for psychotic depression.
Topics: Adolescent; Adult; Affective Disorders, Psychotic; Age Factors; Aged; Aged, 80 and over; Antipsychotic Agents; Benzodiazepines; Double-Blind Method; Drug Resistance; Drug Therapy, Combination; Female; Humans; Logistic Models; Male; Middle Aged; Olanzapine; Patient Dropouts; Placebos; Sertraline | 2012 |
Sustaining remission of psychotic depression: rationale, design and methodology of STOP-PD II.
Topics: Adolescent; Adult; Affective Disorders, Psychotic; Aged; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Double-Blind Method; Drug Therapy, Combination; Humans; Middle Aged; Olanzapine; Remission Induction; Secondary Prevention; Sertraline; Young Adult | 2013 |
Sertraline as monotherapy in the treatment of psychotic and nonpsychotic depression.
Topics: Adolescent; Adult; Affective Disorders, Psychotic; Aged; Brief Psychiatric Rating Scale; Depressive Disorder; Female; Hospitalization; Humans; Male; Middle Aged; Practice Guidelines as Topic; Practice Patterns, Physicians'; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Sex Factors; Treatment Outcome | 2003 |
Treatment of chronic depression with sertraline or imipramine: preliminary blinded response rates and high rates of undertreatment in the community.
Topics: 1-Naphthylamine; Adult; Affective Disorders, Psychotic; Aged; Chronic Disease; Depression; Female; Follow-Up Studies; Humans; Imipramine; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1995 |
The Brown Assessment of Beliefs Scale: reliability and validity.
Topics: 1-Naphthylamine; Adult; Affective Disorders, Psychotic; Awareness; Brief Psychiatric Rating Scale; Delusions; Factor Analysis, Statistical; Female; Humans; Male; Mental Disorders; Obsessive-Compulsive Disorder; Personality Inventory; Prognosis; Psychiatric Status Rating Scales; Psychometrics; Reproducibility of Results; Sensitivity and Specificity; Sertraline; Severity of Illness Index; Somatoform Disorders; Tape Recording; Treatment Outcome | 1998 |
3 other study(ies) available for sertraline and Affective Disorders, Psychotic
| Article | Year |
|---|---|
A case of psychotic depression successfully treated with sertraline as monotherapy.
Topics: Affective Disorders, Psychotic; Antidepressive Agents; Female; Humans; Middle Aged; Sertraline | 2014 |
The impact of ziprasidone in combination with sertraline on visually-evoked event-related potentials in depressed patients with psychotic features.
Topics: Adult; Affective Disorders, Psychotic; Aged; Antipsychotic Agents; Data Interpretation, Statistical; Drug Therapy, Combination; Evoked Potentials, Visual; Female; Humans; Male; Middle Aged; Piperazines; Prolactin; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Thiazoles | 2007 |
Serum levels of clozapine and norclozapine in patients treated with selective serotonin reuptake inhibitors.
Topics: 1-Naphthylamine; Adult; Affective Disorders, Psychotic; Aged; Ambulatory Care; Clozapine; Drug Interactions; Drug Therapy, Combination; Fluoxetine; Humans; Middle Aged; Paroxetine; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Sertraline; Stimulation, Chemical | 1996 |